| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10219894 | European Journal of Obstetrics & Gynecology and Reproductive Biology | 2018 | 6 Pages |
Abstract
KRAS, HNF1β, PIK3CA, PPP2R1A, and ARID1A immunostaining scores in endometriomas previous to OCCC were significantly different than in endometriomas with no malignancy occurring in subsequent follow-ups, and were single predictors of OCCC. Hence, immunostaining with these biomarkers may be a method of identifying patients with endometrioma who have the potential to develop OCCC.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Ercan Bastu, Semen Onder, Irem Demiral, Mehmet Ozsurmeli, Gulsah Keskin, Ozguc Takmaz, Selin Ozaltin, Husnu Gorgen, Mete Gungor, Ekrem Yavuz, Faruk Buyru,